We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiplex PCR Developed for Neglected Infectious Diseases

By LabMedica International staff writers
Posted on 01 Aug 2019
Print article
Image: The Applied Biosystems Veriti HID 96-Well Thermal Cycler (Photo courtesy of Thermo Fisher Scientific).
Image: The Applied Biosystems Veriti HID 96-Well Thermal Cycler (Photo courtesy of Thermo Fisher Scientific).
Scrub typhus, murine typhus, and leptospirosis are diagnosed as acute undifferentiated febrile illness. Diagnostic tests for these diseases depend on antibody detection. However, antibody detection is still limited by its tendency to return negative results during the early phase of these diseases.

Early clinical manifestations of scrub typhus, murine typhus, and leptospirosis, such as high fever, headache, muscular pain, and anorexia, are non-specific and usually diagnosed as acute undifferentiated febrile illness. These clinical manifestations range from mild, severe, to possibly fatal.

Scientists at the Chulalongkorn University (Bangkok, Thailand) and their colleagues used 83 EDTA blood samples taken from patients presented with acute undifferentiated febrile illness at various institutions. Patients included were over 18 years old, having acute fever (38 °C or higher), exhibiting non-specific symptoms, (headache, muscular pain, anorexia, and rash for 3–5 days), and tested negative for both influenza and dengue antigens.

The team developed a multiplex polymerase chain reaction PCR to combine three primer pairs that target specific genes encoding 56-kDa TSA of Orientia tsutsugamushi, 17-kDa antigen of Rickettsia typhi, and LipL32 of Leptospira interrogans and evaluate its performance in comparison to the standard serological tests. Multiplex PCR amplification was performed on a Thermal Cycler. Specificity of the multiplex PCR was tested with unrelated pathogens.

Multiplex PCR results were positive in 39 samples (47%), consisting of 22 samples of scrub typhus (26.5%), 11 samples of leptospirosis (13.25%), five samples of murine typhus (6.02%), and one sample of co-infection between scrub typhus and leptospirosis (1.2%). Twenty samples were detected by both serological methods and multiplex PCR. Nineteen samples were detected only by multiplex PCR but tested negative by standard serological methods. The diagnostic sensitivity and specificity of multiplex PCR were 100% and 70%, respectively, when serological methods were used as gold standard. Positive predictive value and negative predictive value of this assay were 51% and 100%, respectively.

The authors concluded that they had developed a novel multiplex PCR assay for identifying causative agents of scrub typhus, murine typhus, and leptospirosis in blood samples. This method is a rapid, sensitive, and specific diagnostic test. The multiplex PCR assay will become useful for the development of better health care and treatment of patients presented with acute undifferentiated febrile illness, particularly in endemic areas of these diseases. The study was published on July 8, 2019, in the journal PLOS Neglected Tropical Diseases.

Related Links:
Chulalongkorn University

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.